0.1969
-0.0053
(-2.62%)
As of 8:02:49 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-105,398.0000
-116,480.0000
-279,971.0000
-207,853.0000
-113,924.0000
Investing Cash Flow
45,151.0000
93,175.0000
71,681.0000
143,238.0000
3,897.0000
Financing Cash Flow
177.0000
2,528.0000
141,882.0000
10,260.0000
278,837.0000
End Cash Position
11,921.0000
67,912.0000
88,689.0000
155,097.0000
209,452.0000
Capital Expenditure
-75.0000
-592.0000
-8,333.0000
-33,221.0000
-630.0000
Issuance of Capital Stock
--
990.0000
140,591.0000
--
271,687.0000
Free Cash Flow
-105,473.0000
-117,072.0000
-288,304.0000
-241,074.0000
-114,554.0000
12/31/2020 - 7/19/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KK3A.BE Cytokinetics Inc
48.20
+0.42%
8AW0.BE Ocean Biomedical Inc
0.1830
+1.10%
2UV.F Applied Therapeutics, Inc.
0.5470
+6.21%
AT20.F Atara Biotherapeutics, Inc.
8.05
+8.05%
8AW0.F Ocean Biomedical, Inc.
0.1710
-22.27%
3G0.BE Altimmune Inc
6.75
+0.51%
2UV.DU Applied Therapeutics Inc
0.5570
-3.05%
0M4.DU Mersana Therapeutics Inc
0.6036
+2.20%
1VT.DU Viking Therapeutics Inc
32.57
+1.31%
NV4.F Cellectar Biosciences, Inc.
0.2160
+8.00%